Bio-Techne vs Universal Health Services
Bio-Techne (TECH), health care, and Universal Health Services (UHS), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Bio-Techne is worth $11.4B on the stock market and Universal Health Services $11.1B: Bio-Techne is valued at 3% more. Bio-Techne trades at 66.6 times earnings and Universal Health Services at 8.0; operating margins in their latest fiscal years were 20.7% and 11.5%. Over the past year Bio-Techne's share price has moved +25.2% and Universal Health Services's -13.6%.
Key facts
- Bio-Techne market value
- $11.4B
- Universal Health Services market value
- $11.1B
- Bio-Techne P/E
- 66.6
- Universal Health Services P/E
- 8.0
- Bio-Techne revenue
- $1.2BFY to 2026-06-30
- Universal Health Services revenue
- $17.4BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Bio-Techne | Universal Health Services |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2026-06-30 | 2025-12-31 |
| Size | ||
| Market cap | $11.4Bhigher | $11.1Blower |
| Revenue | $1.2Blower | $17.4Bhigher |
| Earnings | $181.9Mlower | $1.5Bhigher |
| Employees | 3,000lower | 102,000higher |
| Total assets | $2.6Blower | $15.5Bhigher |
| Valuation | ||
| P/E | 66.6higher | 8.0lower |
| P/S | 9.4higher | 0.6lower |
| P/B | 5.3higher | 1.5lower |
| Dividend yield | 0.33%lower | 0.40%higher |
| Profitability | ||
| Operating margin | 20.7%higher | 11.5%lower |
| Balance sheet | ||
| Net assets | $2.1Blower | $7.3Bhigher |
| Total liabilities | $478.5Mlower | $8.1Bhigher |
| Total debt | $200Mlower | $4.8Bhigher |
| Cash on hand | $264.7Mhigher | $137.8Mlower |
| Price change | ||
| Today | -0.22%higher | -2.94%lower |
| 1 year | +25.2%higher | -13.6%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Bio-Techne only (7)
- Sequoia Fund team3.9%
- Wallace Weitz1.3%
- Lee Ainslie1.0%
- Mairs & Power team0.8%
- Henry Ellenbogen0.3%
- Paul Tudor Jones0.3%
- Larry Robbins0.1%
Universal Health Services only (5)
- Richard Pzena1.3%
- Matthew McLennan1.3%
- Louis Bacon0.7%
- Josef Lakonishok0.3%
- Ray Dalio (founder)0.1%
Percentages are each holding's share of that investor's reported portfolio. Who owns TECH · Who owns UHS
More on Bio-Techne
Further comparisons
Bio-Techne against its closest peers
Universal Health Services against its closest peers
Learn
Questions and answers
Which is bigger, Bio-Techne or Universal Health Services?
By market value, Bio-Techne is the larger: $11.4B against $11.1B for Universal Health Services. By revenue in its latest fiscal year, Universal Health Services is the larger: $17.4B against $1.2B for Bio-Techne.
Which has the higher P/E ratio?
Bio-Techne: 66.6, against 8.0 for Universal Health Services. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Bio-Techne: 20.7%, against 11.5% for Universal Health Services. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has the higher dividend yield?
Universal Health Services: 0.40%, against 0.33% for Bio-Techne. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
Universal Health Services: $4.8B, against $200M for Bio-Techne. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Bio-Techne and Universal Health Services?
None of the tracked superinvestors holds both in their latest 13F filing. 7 hold Bio-Techne and 5 hold Universal Health Services.
Cite this page
Funkfolio, “Bio-Techne vs Universal Health Services”, data as of 17 November 2026. https://funkfolio.com/compare/tech-vs-uhs
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.